General description
A Certified Spiking Solution® suitable for use as starting material in calibrators or controls for a variety of LC/MS or GC/MS applications from clinical and diagnostic testing to endocrinology and sports testing. 6ß-Hydroxytestosterone is a major urinary metabolite of testosterone, a hormone from the androgen group of steroids. Testosterone is an important sex hormone and anabolic steroid used as a performance-enhancing drug.
Legal Information
CERILLIANT is a registered trademark of Cerilliant Corporation
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Cerilliant Corporation
Molecular Weight: 304.42. Empirical Formula: C19H28O3. grade: certified reference material. Quality Level: 300. form: liquid. feature: Snap-N-Spike®. /Snap-N-Shoot®. . packaging: ampule of 1 . mL. manufacturer/tradename: Cerilliant®. . concentration: 100 . μ. g/mL in methanol. technique(s): gas chromatography (GC): suitable, liquid chromatography (LC): suitable. application(s): clinical testing. format: single component solution. storage temp.: −. 20°C. SMILES string: C[C@]12CC[C@H]3[C@@H](C[C@@H](O)C4: CC(: O)CC[C@]34C)[C@@H]1CC[C@@H]2O. InChI: 1S/C19H28O3/c1-18-7-5-11(20)9-15(18)16(21)10-12-13-3-4-17(22)19(13,2)8-6-14(12)18/h9,12-14,16-17,21-22H,3-8,10H2,1-2H3/t12-,13-,14-,16+,17-,18+,19-/m0/s1. InChI key: XSEGWEUVSZRCBC-ZVBLRVHNSA-N. Pictograms: GHS02,GHS06,GHS08. Signal Word: Danger. Hazard Statements: H225 - H301 + H311 + H331 - H370. Precautionary Statements: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311. Hazard Classifications: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1. Target Organs: Eyes. Storage Class Code: 3 - Flammable liquids. WGK: WGK 2. Flash Point(F): 49.5 °F - closed cup. Flash Point(C): 9.7 °C - closed cup.- UPC:
- 51182009
- Condition:
- New
- HazmatClass:
- Yes
- MPN:
- H-059-1ML
- CAS:
- 62-99-7
akash.verma@cenmed.com
(732) 447-1115





